NewAmsterdam Pharma pany N.V.(NAMS) - 2025 FY - Earnings Call Transcript

NewAmsterdam Pharma Company (NasdaqGM:NAMS) FY 2025 Conference December 03, 2025 03:15 PM ET Company ParticipantsMichael Davidson - CEOGeoff Meacham - Global Head of Biotech and Pharma ResearchIan Somaiya - CFOGeoff MeachamYeah, the Global Healthcare Conference at Citi. My name's Geoff Meacham. I am the head of healthcare, global head of biotech, pharma research. Fun, fun. We're thrilled today to have NewAmsterdam Pharma. So we have Michael Davidson, CEO. We have Ian Somaiya, CFO. Guys, thanks a lot for the ...